XML 32 R22.htm IDEA: XBRL DOCUMENT
v3.22.2

Stock-Based Compensation Expense | 6 Months Ended
--- | ---
Jul. 03, 2022
Share-Based Payment Arrangement [Abstract] |
Shareholders' Equity and Share-based Payments | Stock-Based Compensation Expense Stock Plans The Company’s stock-based awards that result in compensation expense consist of stock options, restricted stock units ("RSUs"), and performance restricted stock units ("PRSUs"). As of July 3, 2022, the Company had 14,250,000 shares available for grant under its stock plans. Stock options are granted with an exercise price equal to the market value of the Company’s common stock at the grant date and generally vest over four or five years based upon continuous service and expire ten years from the grant date. RSUs generally vest upon three or four years of continuous employment or incrementally over such three or four-year period. PRSUs generally vest upon three years of continuous employment and achievement of performance criteria established by the Compensation Committee of our Board of Directors on or prior to the grant date. Participants are not entitled to dividends on RSUs or PRSUs. Stock Options The following table summarizes the Company’s stock option activity for the six-month period ended July 3, 2022:
| Shares (in thousands) |  | Weighted- Average Exercise Price |  | Weighted- Average Remaining Contractual Term (in years) |  | Aggregate Intrinsic Value (in thousands)
Outstanding as of December 31, 2021 | 7,610 |  |  | $ | 49.38 |  |  |  |  |
Granted | 1,030 |  |  | 64.02 |  |  |  |  |
Exercised | (133) |  |  | 44.66 |  |  |  |  |
Forfeited or expired | (118) |  |  | 59.53 |  |  |  |  |
Outstanding as of July 3, 2022 | 8,389 |  |  | $ | 51.11 |  |  | 6.47 |  | $ | 26,951 |
Exercisable as of July 3, 2022 | 4,347 |  |  | $ | 43.46 |  |  | 5.30 |  | $ | 26,615 |
Options vested or expected to vest as of July 3, 2022 (1) | 7,927 |  |  | $ | 50.45 |  |  | 6.36 |  | $ | 26,938 |
(1) In addition to the vested options, the Company expects a portion of the unvested options to vest at some point in the future. Options expected to vest are calculated by applying an estimated forfeiture rate to the unvested options. The fair values of stock options granted in each period presented were estimated using the following weighted-average assumptions:
| Three-months Ended |  | Six-months Ended
| July 3, 2022 |  | July 4, 2021 |  | July 3, 2022 |  | July 4, 2021
Risk-free rate | 1.9 | % |  | 1.5 | % |  | 1.9 | % |  | 1.3 | %
Expected dividend yield | 0.53 | % |  | 0.31 | % |  | 0.40 | % |  | 0.27 | %
Expected volatility | 37 | % |  | 39 | % |  | 37 | % |  | 39 | %
Expected term (in years) | 6.1 |  | 7.1 |  | 5.2 |  | 5.8
Risk-free rate The risk-free rate was based upon a treasury instrument whose term was consistent with the contractual term of the option. Expected dividend yield Generally, the current dividend yield is calculated by annualizing the cash dividend declared by the Company’s Board of Directors and dividing that result by the closing stock price on the grant date. Expected volatility The expected volatility was based upon a combination of historical volatility of the Company’s common stock over the contractual term of the option and implied volatility for traded options of the Company’s stock. Expected term The expected term was derived from the binomial lattice model from the impact of events that trigger exercises over time. The weighted-average grant-date fair values of stock options granted during the three-month and six-month periods ended July 3, 2022 were $18.21 and $22.33, respectively, and during the three-month and six-month periods ended July 4, 2021 were $32.07 and $33.47, respectively. The total intrinsic values of stock options exercised for the three-month and six-month periods ended July 3, 2022 were $934,000 and 3,099,000, respectively, and for the three-month and six-month periods ended July 4, 2021 were $11,621,000 and $53,948,000, respectively. The total fair values of stock options vested for the three-month and six-month periods ended July 3, 2022 were $1,188,000 and $26,723,000, respectively, and for the three-month and six-month periods ended July 4, 2021 were $1,830,000 and $37,430,000, respectively. Restricted Stock Units (RSUs) The following table summarizes the Company's RSUs activity for the six-month period ended July 3, 2022:
| Shares (in thousands) |  | Weighted-Average Grant Date Fair Value
Nonvested as of December 31, 2021 | 823 |  |  | $ | 65.26 |
Granted | 481 |  |  | 63.37 |
Vested | (74) |  |  | 81.31 |
Forfeited or expired | (36) |  |  | 66.56 |
Nonvested as of July 3, 2022 | 1,194 |  |  | $ | 63.47 |
The fair value of RSUs is determined based on the observable market price of the Company's stock on the grant date less the present value of expected future dividends. The weighted-average grant-date fair values of RSUs granted during the three-month and six-month periods ended July 3, 2022 were $45.25 and $63.37, respectively, and during the three-month and six-month periods ended July 4, 2021 were $75.98 and $87.46, respectively. There were 20,000 and 74,000 RSUs that vested during the three-month and six-month periods ended July 3, 2022, respectively, and 13,000 and 15,000 that vested during the three-month and six-month periods ended July 4, 2021, respectively. Performance Restricted Stock Units (PRSUs) The following table summarizes the Company's PRSUs activity for the six-month period ended July 3, 2022:
| Shares (in thousands) |  | Weighted-Average Grant Date Fair Value
Nonvested as of December 31, 2021 | — |  |  | $ | — |
Granted | 33 |  |  | 62.49 |
Vested | — |  |  | — |
Forfeited or expired | — |  |  | — |
Nonvested as of July 3, 2022 | 33 |  |  | $ | 62.49 |
No PRSUs were granted or vested during the three-month period ended July 3, 2022. No PRSUs were granted or vested during the three-month and six-month periods ended July 4, 2021. The fair value of PRSUs is calculated using the Monte Carlo simulation model to estimate the probability of satisfying the service and market conditions stipulated in the award grant. Stock-Based Compensation Expense The Company stratifies its employee population into two groups: one consisting of senior management and another consisting of all other employees. The Company currently applies an estimated annual forfeiture rate of 7% to all stock-based awards for senior management and a rate of 12% for all other employees. Each year during the first quarter, the Company revises its forfeiture rate based on updated estimates of employee turnover. This resulted in an increase to compensation expense of $1,536,000 in 2022 and a decrease to compensation expense of $255,000 in 2021. As of July 3, 2022, total unrecognized compensation expense related to non-vested equity awards, including stock options, RSUs and PRSUs, was $69,142,000, which is expected to be recognized over a weighted-average period of 1.6 years. The total stock-based compensation expense and the related income tax benefit recognized for the three-month period ended July 3, 2022 were $12,997,000 and $2,044,000, respectively, and for the six-month period ended July 3, 2022 were $28,053,000 and $4,363,000, respectively. The total stock-based compensation expense and the related income tax benefit recognized for the three-month period ended July 4, 2021 were $10,730,000 and $1,651,000, respectively, and for the six-month period ended July 4, 2021 were $22,739,000 and $3,464,000, respectively. No compensation expense was capitalized as of July 3, 2022 or December 31, 2021. The following table presents the stock-based compensation expense by caption for each period presented on the Consolidated Statements of Operations (in thousands):
| Three-months Ended |  | Six-months Ended
| July 3, 2022 |  | July 4, 2021 |  | July 3, 2022 |  | July 4, 2021
Cost of revenue | $ | 482 |  |  | $ | 351 |  |  | $ | 1,045 |  |  | $ | 599 |
Research, development, and engineering | 3,851 |  |  | 3,064 |  |  | 8,299 |  |  | 7,067 |
Selling, general, and administrative | 8,664 |  |  | 7,315 |  |  | 18,709 |  |  | 15,073 |
| $ | 12,997 |  |  | $ | 10,730 |  |  | $ | 28,053 |  |  | $ | 22,739 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI https://asc.fasb.org/topic&trid=2208762 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI https://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration